Skip to main content
. 2019 Dec 27;11(2):505–517. doi: 10.1002/jcsm.12517

Table 5.

Significance of the association between protein levels and time to loss of ambulation, after correction for age

Protein Antibody P‐value FDR
KRT10 HPA012014 0.0018 0.0388
MDH2 HPA019848 0.0026 0.0388
DES HPA018803 0.0076 0.0758
MYL3 HPA016564 0.0139 0.1044
CK HPA001254 0.0221 0.1204
COL1A1 HPA011795 0.0261 0.1204
ETFA HPA018990 0.0281 0.1204
C4BPA HPA000926 0.0375 0.132
LCP1 HPA019493 0.0396 0.132
TNNT2 HPA015774 0.099 0.2736
PDZK1 HPA005755 0.1088 0.2736
MYOM3 HPA029752 0.1198 0.2736
RELB HPA011985 0.1276 0.2736
AKAP1 HPA008691 0.1277 0.2736
NES HPA026111 0.1594 0.3188
ANKRD2 HPA040884 0.1975 0.3703
LDHB HPA019007 0.2373 0.4162
TNNT3 HPA037810 0.259 0.4162
TTN HPA007042 0.2636 0.4162
HDAC2 HPA011727 0.3182 0.4651
GSN HPA070538 0.3424 0.4651
BASP1 HPA050333 0.3428 0.4651
C3 HPA003563 0.3599 0.4651
CFH HPA049176 0.3721 0.4651
C4A HPA048287 0.4092 0.4765
MGP HPA014274 0.4267 0.4765
MAP 4 HPA038150 0.4289 0.4765
FH HPA027341 0.4797 0.4926
CA3 HPA021775 0.4864 0.4926
ENO3 HPA000793 0.4926 0.4926

Results of the test on the significance of each antibody in a Cox model where we controlled for baseline age. P‐value is the P‐value of the Wald test on the significance of the antibody (main effect + interaction with baseline age), and FDR is the P‐value after application of the Benjamini–Hochberg multiple testing correction.